L.P. ACORN BIOVENTURES - 14 Aug 2025 SCHEDULE 13G/A Report for Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB)

Filing Manager
L.P. ACORN BIOVENTURES
Reporting Manager
Anders Hove
Security
Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
YMAB
Shares outstanding
44,232,814 shares
Disclosed Ownership
3,096,297 shares
Ownership
7%
Form type
SCHEDULE 13G/A
Filing time
15 Aug 2025, 10:31:34 UTC
Date of event
14 Aug 2025
Next filing
20 Aug 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 3% 1,301,686 0 1,301,686 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 3% 1,301,686 0 1,301,686 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 4% 1,794,611 0 1,794,611 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 4% 1,794,611 0 1,794,611 Anders Hove Manager
Anders Hove 7% 3,096,297 0 3,096,297 Anders Hove Individually